Los Angeles, CA, February 23, 2006 – It has been known for many years that healthy bones mean more than just supplementing with calcium and vitamin D. A recently released study observes that calcium is not effective against osteoporosis, a fact known by the dietary supplement industry for many years.
Bone-Up, in the marketplace for almost 20 years, has never been just calcium and Vitamin D. Jarrow Formulas is now pleased to announce the following:
Ultra Bone-Up™, the most complete nutritional regimen available for bones, has been Up-Formulated and includes in “Supplement Facts” order:
- Vitamin C
- Vitamin D3
- Vitamin K1
- MK-7 (Vitamin K2 as Menaquinone-7)
- Folic Acid
- Methyl B12
- Microcrystalline Hydroxyapatite (MCHA)
- SDG Flax Lignans
- Glucosamine HCI
Notable additions to the all-new Ultra Bone-Up formula are increased Vitamin D3, MK-7, SDG lignans from flaxseed, Methyl B-12, MSM and Curcumin.
Vitamin D, especially in its prohormone form as D3, is critical for the absorption of dietary calcium. Recent research has established that 1,000 I.U. of vitamin D per day is critical to maintain bone health, reduce the risk of prostate, breast and colon cancer and enhance immunity. Natto, a source of menaquinone-7 (MK-7), a traditional Japanese food that is made from fermented soybeans, contains the very special form of Vitamin K2 that stimulates the synthesis of the GLA protein in bones. Epidemiological data supports its role in reducing cardiovascular risk as well. Women consuming natto exhibit significantly higher bone mineral density and fewer osteoporotic fractures.
Flax is also traditionally associated with bone health – most notably from the lignans – which are typically abundant in flaxseed. However, flax lignans are far more than just fiber – they are phytoestrogens. One reason that eating fruits, vegetables and legumes promotes health and reduces the risk of cancer is that phytoestrogens found in these foods help protect us from environmental toxins. The same can be said for flax lignans, especially secoisolariciresinol diglycoside (SDG) flax lignans. SDG lignans activate osteoblasts, the cells that build bone.
Curcumin has also been added to the new Ultra Bone-Up formulation. Curcumin has been shown to reduce the activation of osteoclasts, the cells that tear bone down.
Finally, methyl B12 was added to reduce homocysteine, an amino acid for which elevated levels are associated with osteoporosis
Jarrow Formulas also wants to remind its customers of the amazingly successful study using BioSil™, biologically active silicon concentrated and stabilized with choline chloride, done in England and published last year that actually demonstrated an increase in femur bone density after a year in osteopenic and osteoporotic women.
Jarrow Formulas® Ultra Bone-Up is the complete nutritional regimen for bones and joints that features Australian bovine bone hydroxyapatite, the most effective source of calcium available. Hydroxyapatite is the same form of calcium found in human bone tissue.
Jarrow Formulas, Inc. is a nutritional supplement formulator and marketer founded in 1977 and incorporated in 1988. The company markets its products throughout the United States and internationally in more than 20 countries in Europe, Asia, Israel and Latin America. The company offers a complete line of nutritional products that includes vitamins, minerals, probiotics, standardized herbal concentrates, amino acids, enzymes and enteral nutrition formulations. Jarrow Formulas, Inc. is active in regulatory affairs, helping to maintain American’s rights to free access to dietary supplements. Its products are manufactured by Jarrow Industries Incorporated, a pharmaceutical quality facility located in Santa Fe Springs, CA. For more information, contact Mark Becker, Director, Advertising/Communications toll free at (800) 726-0886 or access the Jarrow Formulas Web site at www.Jarrow.com.